PatelNPBrandtCPYowlerCJ. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team. J Burn Care Res. 2006;27(3):310–313.
2.
KoppBJMrsanMErstadBL. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm. 2007;64(23):2483–2487.
3.
Kane-GillSReaRSVerricoMM. Adverse-drug event rates for high-cost and high-use drugs in the intensive care unit. Am J Health Syst Pharm. 2006;63(19):1876–1881.
4.
RudisMIBrandlKM. Position paper on critical care pharmacy services. Crit Care Med. 2000;28(11):3746–3750.
5.
MacLarenRDevlinJWMartinSJ. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006;40(4):612–618.
